Inactive Instrument
Canntab Therapeutics Limited Stock
Stocks
CTABF
CA1377991023
Pharmaceuticals
OTC Markets Traded| 1 day | -99.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Tech/Sci/R&D Officer | - | 15/05/2020 | |
Frank Candido
IRC | Investor Relations Contact | 61 | 01/09/2018 |
Eric Malinski
SAM | Sales & Marketing | - | 01/05/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/6/24 A | Option | Director | 100,000 | 0.2570% | ||
| 2/6/24 A | Option | Director | 100,000 | 0.2570% | ||
| 2/22/22 A | Sell | Chief Executive Officer | 400,000 | 1.0717% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -99.00% | -.--% | - | - | 38 | |
| -1.55% | -1.03% | -9.29% | -6.00% | 13.66B | |
| -2.68% | -1.61% | -32.44% | -54.39% | 5.24B | |
| -0.64% | +4.33% | +5.28% | +8.07% | 5.16B | |
| -2.08% | -0.96% | +0.86% | -33.25% | 4.16B | |
| -1.35% | +2.39% | -9.47% | -4.11% | 3.75B | |
| -0.61% | -0.87% | -3.39% | +4.67% | 3.6B | |
| -0.82% | -0.06% | -4.96% | +12.93% | 3.51B | |
| -0.89% | +0.26% | -14.66% | -23.12% | 2.47B | |
| -1.53% | 0.00% | -4.10% | +49.80% | 1.9B | |
| Average | -11.11% | -2.37% | -8.02% | -5.05% | 4.83B | |
| Weighted average by Cap. | -1.44% | -2.68% | -8.63% | -8.72% |
Employees
-
Sector
Pharmaceuticals
